François SALACHAS, neurologist (Sorbonne University - APHP) and coordinator of the iCRIN SLA of Paris Brain Institute, explains the causes, symptoms and treatments of Charcot’s disease (SLA).
Comprendre en 2 minutes
News that might interest you
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain
...
09.05.2024
Research, science & health
A joint study by teams from the Paris Brain Institute at the Pitié-Salpêtrière hospital and from Inria (Rennes and Paris centers) has revealed for the first-time plasma microRNA signatures in individuals with or presymptomatic of fronto-temporal
...
12.04.2020
Research, science & health
Paris, October 19th, 2020 - ALS is characterized by the degeneration of motor neurons resulting in a progressive and irreversible deficit in walking and speech, until a complete paralysis of all muscles, including those controlling respiration. The
...
10.20.2020
Research, science & health
The neuromuscular junction is a zone that enables transfer of information from the nervous system to muscles, and is affected in Amyotrophic Lateral Sclerosis. The team led by Edor Kabashi at the Institut du Cerveau – ICM focused on the role of
...
03.24.2017
Research, science & health
The Paulo Gontijo Institute awarded the International Medicine PG Award to Edor Kabashi, team leader at the Brain and Spine Institute – Institut du Cerveau, for his research on the development of new models and new therapeutic avenues for Amyotrophic
...
10.26.2016
Research, science & health
Professor Adrian Isaacs, neuroscientist at the London University College (UCL), was the Institut du Cerveau - ICM's guest on April 18, 2016. On this occasion, he discusses his research on C9orf72 gene, which unusual mutation is at the origin of two
...
05.30.2016
Research, science & health